| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
PSIVIDA LIMITED (PSD)
Stock Code: PSD
Listing Date: 1987-09-17 00:00:00
Website: http://www.psivida.com.au/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Commercialisation of a unique and exciting bio-engineering platform technology known as BioSilicon which is based on exploiting the biofunctionality of the silicon semiconductor in a variety of healthcare applications.
Address:
28 The Esplanade, BGC Building, Level 12
PERTH
WA 6000
Phone: 08 9227 8327
Fax: 08 9227 6838
Executives & Directors
Dr David Mazzo, Non Exec. Chairman
Dr Paul Ashton, Executive Director, Managing Director
Mr Stephen Lake, Non Exec. Director
Mr Michael Rogers, Non Exec. Director
Mr Michael Soja, CFO
Mr Brian Leedman, Investor Relations
Ms Lori Freedman
Mr Winton Willesee, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
Excellence in Biotechnology Investment - Dr Paul Ashton, MD, pSivida Ltd
|
|
Wed, 23 Apr 2008 05:45PM |
| Interim Results | Thu, 21 Feb 2008 | |
| Annual General Meeting | Tue, 27 Nov 2007 11:30AM |
|
| Full Year Results | Fri, 31 Aug 2007 | |
| Interim Results | Wed, 28 Feb 2007 | |
| Annual General Meeting | Wed, 15 Nov 2006 10:00AM |
|
| EGM | Tue, 19 Sep 2006 03:00PM |
|
| Full Year Results | Thu, 14 Sep 2006 | |
| Interim Results | Thu, 16 Mar 2006 | |
| Annual General Meeting | Tue, 15 Nov 2005 10:00AM |
PSIVIDA LIMITED (PSD)
| Removal from Official List at close 20 June 2008 | Tue, 17 Jun 2008 |
| Compliance with ASX Listing Rule 3.1 | Wed, 11 Jun 2008 |
| Court Order Approving US Reincorporation | Wed, 11 Jun 2008 |
| pSivida moves to complete reincorporation as a US company | Wed, 11 Jun 2008 |
| Suspension from Official Quotation | Wed, 11 Jun 2008 |
| pSivida Receives Court Approval for US Reincorporation | Tue, 10 Jun 2008 |
| EGM Chairman`s Address | Fri, 6 Jun 2008 |
| Scheme Meeting Chairman`s Address | Fri, 6 Jun 2008 |
| Scheme Meeting Results | Fri, 6 Jun 2008 |
| Change to indicative timetable for Scheme of Arrangement | Wed, 4 Jun 2008 |
| pSivida to present at the Rodman and Renshaw Healthcare Conf | Mon, 19 May 2008 |
| pSivida new trial to treat Age Related Macular Degeneration | Fri, 9 May 2008 |
| Information Memorandum - US Reincorporation | Tue, 6 May 2008 |
| pSivida Shareholder Meeting, 6 June 2008 | Tue, 6 May 2008 |
| pSivida March 2008 Quarter - Commentary and Highlights | Wed, 30 Apr 2008 |
| Appendix 4C - quarterly | Wed, 30 Apr 2008 |
| pSivida proposed reincorporation in the US - maintain ASX | Fri, 18 Apr 2008 |
| pSivida clears Opes Prime overhang | Tue, 15 Apr 2008 |
| pSivida appoints new Company Secretary | Thu, 27 Mar 2008 |
| DSMB again supports continuation of Medidur for DME trial | Tue, 25 Mar 2008 |
| Open Briefing. pSivida. Alimera Agreement Amendment | Wed, 19 Mar 2008 |
| pSivida generates A$82m from amended licensing amendment | Mon, 17 Mar 2008 |
| Trading Halt | Fri, 14 Mar 2008 |
| pSivida to present today at Sachs Conference in Boston | Mon, 25 Feb 2008 |
| Half Year Accounts | Thu, 21 Feb 2008 |
| pSivida receives first RD payments from Pfizer | Wed, 20 Feb 2008 |
| Appendix 4C - quarterly | Thu, 31 Jan 2008 |
| pSivida December 2007 Quarter - Commentary and Highlights | Thu, 31 Jan 2008 |
| pSivida pancreatic cancer results released | Tue, 29 Jan 2008 |
| Change of Director`s Interest Notice | Wed, 5 Dec 2007 |
| Appendix 3B | Fri, 30 Nov 2007 |
| Results of Annual General Meeting and Presentation | Tue, 27 Nov 2007 |
| pSivida September 2007 Quarter - Commentary and Highlights | Wed, 31 Oct 2007 |
| Appendix 4C - quarterly | Wed, 31 Oct 2007 |
| US Form Annual Report to shareholders | Fri, 26 Oct 2007 |
| Notice of Annual General Meeting/Proxy Form | Fri, 26 Oct 2007 |
| Annual Report to shareholders | Fri, 26 Oct 2007 |
| DSMB support continuation of Phase III Medidur for DME trial | Wed, 17 Oct 2007 |
| pSivida completes enrollment of Phase III Medidur for DME | Mon, 8 Oct 2007 |
| Full Year Statutory Accounts | Fri, 28 Sep 2007 |
| pSivida to present at the Astrologers Fund Conference in NYC | Mon, 10 Sep 2007 |
| Preliminary Final Report | Fri, 31 Aug 2007 |
| pSivida enrollment begins on Human PK Study for Medidur | Wed, 22 Aug 2007 |
| PSD completes recruitment of cancer trial/prelim results | Mon, 13 Aug 2007 |
| PSD completes recruitment of cancer trial/prelim results | Mon, 13 Aug 2007 |
| pSivida appoints new Australian Non-executive Director | Fri, 3 Aug 2007 |
| pSivida Managing Director Open Briefing Interview | Thu, 2 Aug 2007 |
| pSivida June 2007 Quarter - Commentary and Highlights | Tue, 31 Jul 2007 |
| Appendix 4C - quarterly | Tue, 31 Jul 2007 |
| Appendix 3B | Fri, 20 Jul 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.